IVF pregnancy study to prevent pre-eclampsia in high-risk women
Part of Women’s health & pregnancy clinical trials.
This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are doing IVF/ICSI (assisted reproduction), as a first-time egg recipient or you have PCOS and have not had a baby before
- If you have PCOS, you must meet at least 2 of these: long/irregular periods (over 35 days), higher male-type hormones (by symptoms or blood tests), and typical “polycystic” ovary findings or blood markers
- You must not already have high blood pressure before pregnancy (or develop new high blood pressure before 20 weeks)
- You must not have known type 1 or type 2 diabetes before pregnancy
- Your thyroid and other hormone conditions must be controlled (not clearly overactive or underactive) with treatment
- You must not have certain major health conditions (heart, kidney, lupus, antiphospholipid syndrome, severe liver problems), and you must not have had pre-eclampsia before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors related to pre-eclampsia (a pregnancy blood-pressure condition) in people who are more than 10 weeks pregnant. It may help improve early understanding and care for future pregnancies.
This study looks at how the body supports pregnancy in the early weeks and whether problems with that support can lead to complications. By tracking pregnancies from the start, researchers hope to find ways to predict and prevent issues like poor placental function.
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
This study tests a new medicine, EG-101, in healthy women to see if it is safe and to learn how the body processes it. This is a first step before studying it in pregnant women with severe pre-eclampsia, a serious condition of high blood pressure during pregnancy.
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
This study tests whether a common diabetes medicine, called metformin, can help pregnant people with early-onset preeclampsia (a serious condition causing high blood pressure) carry their baby longer and reduce risks for both mother and child.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.